Global Digital Diabetes Management Market to Reach USD 70.9 Billion by 2033, Propelled by Rising Prevalence of Diabetes

December 25, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Digital Diabetes Management Market Report by Product Type (Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens, Apps), Device Type (Handheld Devices, Wearable Devices), and Region 2025-2033," the global digital diabetes management market size reached USD 15.6 Billion in 2024. Digital diabetes management refers to the electronic solutions that help in the care, support, and prevention of diabetes. It includes devices, services, platforms, and virtual tools, such as blood glucose meters, smart insulin pumps, mobile applications, online patient portals, and community support and education hubs. Digital diabetes management is widely used for glucose monitoring, diet management, administering doses, medication adjustment, and tracking lifestyle data, such as weight and exercise. It is easy to use, assists in disease self-management, provides a better understanding of an individual’s condition, and offers necessary nutrition, exercise, and general health guidance. Digital diabetes management also aids in improving healthcare processes or preventing diabetes complications, and minimizing medical costs. 

Global Digital Diabetes Management Market Trends:

The rising prevalence of diabetes due to sedentary lifestyles and obesity across the globe is driving the market growth. Digital diabetes management is widely used to keep patients within their targeted blood glucose range, administer medications, provide remote guidance, predict fluctuations, and integrate relevant data from various devices to create a comprehensive picture for personalized recommendations. In addition, the widespread adoption of digital diabetes management among healthcare professionals to quickly access patient information, recommend dose adjustment, and prepare for the next appointment is acting as another growth-inducing factor. Furthermore, the widespread adoption of electronic solutions and devices to provide motivation, offer wellness guidance, and track activities due to the increasing health consciousness among the masses is facilitating the market growth. Apart from this, the integration of big data analytics and artificial intelligence (AI) to provide real-time access to structured and unstructured data and offer customized solutions for hypoglycemia control to patients is positively influencing the market growth. Moreover, the introduction of continuous glucose monitoring (CGM) devices that are convenient, provide accurate information throughout the day, and eliminate the need for the finger-prick test is propelling the market growth. Other factors, including rising expenditure capacities of consumers, increasing investments in research and development (R&D) activities, and rapid digitalization of the healthcare industry, are anticipated to drive the market growth. Looking forward, the market value is projected to reach USD 70.9 Billion by 2033, expanding at a CAGR of 17.39% during 2025-2033.

Market Summary:

  • On the basis of the product type, the market has been divided into smart glucose meters, smart insulin pumps, smart insulin pens, and apps. Among these, smart glucose meters dominate the market.
  • Based on the device type, the market has been bifurcated into handheld and wearable devices, wherein wearable devices exhibit a clear dominance.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. At present, North America represents the largest regional market.
  • The competitive landscape of the industry has also been examined, with some of the key players being Abbott Laboratories, ACON Laboratories Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton, Dickinson and Company, Dexcom Inc., F. Hoffmann-La Roche AG, Medtronic plc, Novo Nordisk A/S, Tandem Diabetes Care Inc. and Terumo Corporation.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product Type, Device Type, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, ACON Laboratories Inc, Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton, Dickinson and Company, Dexcom Inc., F. Hoffmann-La Roche AG, Medtronic plc, Novo Nordisk A/S, Tandem Diabetes Care Inc. and Terumo Corporation
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Digital Diabetes Management Market to Reach USD 70.9 Billion by 2033, Propelled by Rising Prevalence of Diabetes
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials